| Primary |
| Product Used For Unknown Indication |
54.4% |
| Dyspepsia |
16.6% |
| Abdominal Distension |
16.0% |
| Gastrointestinal Disorder |
5.0% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Impaired Gastric Emptying |
1.5% |
| Nausea |
1.1% |
| Gastric Disorder |
0.8% |
| Diabetic Gastroparesis |
0.8% |
| Vomiting |
0.6% |
| Abdominal Pain |
0.2% |
| Drug Use For Unknown Indication |
0.2% |
| Prophylaxis |
0.1% |
| Depression |
0.1% |
| Anaesthesia |
0.1% |
| Gastrointestinal Motility Disorder |
0.1% |
| Irritable Bowel Syndrome |
0.1% |
| Reflux Gastritis |
0.1% |
| Pain |
0.1% |
| Constipation |
0.1% |
|
| Tardive Dyskinesia |
32.0% |
| Extrapyramidal Disorder |
20.7% |
| Dystonia |
12.9% |
| Nervous System Disorder |
6.6% |
| Movement Disorder |
3.3% |
| Dyskinesia |
3.2% |
| Tremor |
3.1% |
| Economic Problem |
2.4% |
| Pain |
2.2% |
| Family Stress |
1.7% |
| Activities Of Daily Living Impaired |
1.7% |
| Incorrect Drug Administration Duration |
1.5% |
| Multiple Injuries |
1.3% |
| Akathisia |
1.3% |
| Unevaluable Event |
1.3% |
| Emotional Disorder |
1.1% |
| Anhedonia |
1.0% |
| Anxiety |
1.0% |
| Quality Of Life Decreased |
1.0% |
| Fear |
0.9% |
|
| Secondary |
| Dyspepsia |
31.7% |
| Abdominal Distension |
31.2% |
| Product Used For Unknown Indication |
16.9% |
| Drug Use For Unknown Indication |
3.7% |
| Gastrointestinal Disorder |
3.6% |
| Nausea |
1.9% |
| Impaired Gastric Emptying |
1.9% |
| Drug Abuse |
1.3% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Vomiting |
0.9% |
| Pain |
0.8% |
| Abdominal Pain |
0.7% |
| Gastric Disorder |
0.7% |
| Thrombosis Prophylaxis |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Hyperemesis Gravidarum |
0.5% |
| Epilepsy |
0.5% |
| Hypertension |
0.5% |
| Drug Exposure During Pregnancy |
0.5% |
| Foetal Exposure During Pregnancy |
0.5% |
|
| Tardive Dyskinesia |
29.7% |
| Extrapyramidal Disorder |
21.1% |
| Dystonia |
16.1% |
| Nervous System Disorder |
15.3% |
| Movement Disorder |
4.2% |
| Dyskinesia |
3.5% |
| Tremor |
2.3% |
| Multiple Injuries |
1.1% |
| Akathisia |
1.0% |
| Restless Legs Syndrome |
0.6% |
| Asthenia |
0.6% |
| Unevaluable Event |
0.6% |
| Vomiting |
0.6% |
| Activities Of Daily Living Impaired |
0.6% |
| Overdose |
0.5% |
| Toxic Epidermal Necrolysis |
0.5% |
| Parkinsonism |
0.5% |
| Essential Tremor |
0.4% |
| Visual Impairment |
0.4% |
| Toxicity To Various Agents |
0.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.0% |
| Drug Use For Unknown Indication |
19.2% |
| Prophylaxis |
7.6% |
| Nausea |
6.2% |
| Pain |
5.7% |
| Hypertension |
5.3% |
| Non-small Cell Lung Cancer |
2.9% |
| Vomiting |
2.6% |
| Constipation |
2.5% |
| Breast Cancer |
2.4% |
| Prophylaxis Of Nausea And Vomiting |
2.3% |
| Depression |
2.3% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Multiple Myeloma |
1.8% |
| Diffuse Large B-cell Lymphoma |
1.8% |
| Diabetes Mellitus |
1.8% |
| Rheumatoid Arthritis |
1.5% |
| Anxiety |
1.5% |
| Premedication |
1.3% |
| Insomnia |
1.3% |
|
| Vomiting |
23.7% |
| Weight Decreased |
7.0% |
| Sepsis |
5.9% |
| Thrombocytopenia |
5.5% |
| Renal Failure Acute |
5.1% |
| Pneumonia |
4.8% |
| Nausea |
4.6% |
| Death |
4.4% |
| Pyrexia |
4.2% |
| Urinary Tract Infection |
3.9% |
| Pulmonary Embolism |
3.8% |
| Renal Failure |
3.6% |
| White Blood Cell Count Decreased |
3.5% |
| Febrile Neutropenia |
3.4% |
| Myocardial Infarction |
2.9% |
| Septic Shock |
2.8% |
| Syncope |
2.8% |
| Dyspnoea |
2.8% |
| Pain |
2.7% |
| Weight Increased |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
30.6% |
| Drug Use For Unknown Indication |
15.4% |
| Mental Disorder |
10.5% |
| Hypertension |
5.9% |
| Somatoform Disorder |
5.6% |
| Anaesthesia |
4.0% |
| Dyspnoea |
4.0% |
| Blood Cholesterol Increased |
3.7% |
| Herpes Zoster |
2.8% |
| Menopause |
2.8% |
| Anaesthetic Complication Neurological |
2.5% |
| Nausea |
2.2% |
| Pain |
1.9% |
| Gastric Disorder |
1.5% |
| Vomiting |
1.5% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Abdominal Pain Upper |
0.9% |
| Bladder Disorder |
0.9% |
| Insomnia |
0.9% |
|
| Drug Interaction |
17.4% |
| Suicidal Ideation |
8.7% |
| Extrapyramidal Disorder |
6.5% |
| Rash |
6.5% |
| Weight Increased |
6.5% |
| Akathisia |
4.3% |
| Cerebrovascular Accident |
4.3% |
| Dystonia |
4.3% |
| Grand Mal Convulsion |
4.3% |
| Headache |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Mydriasis |
4.3% |
| Physical Assault |
4.3% |
| Serotonin Syndrome |
4.3% |
| Sinus Tachycardia |
4.3% |
| Abasia |
2.2% |
| Blood Creatine Phosphokinase Increased |
2.2% |
| Completed Suicide |
2.2% |
| Death |
2.2% |
| Disorientation |
2.2% |
|
